Status:
UNKNOWN
Hysteroscopic Tubal Occlusion Using Amacrylate With or Without Lipidol in Patients With Hydrosalpinx Prior to IVF
Lead Sponsor:
Ain Shams University
Conditions:
Effectiveness of Isoamyl-2-cyanoacrylate With and Without Ethiodized Oil in Occluding Hydrosalpinx Prior to IVF
Eligibility:
FEMALE
25-43 years
Phase:
PHASE3
Brief Summary
Hysteroscopic tubal occlusion using iso-amyl- 2-cyanoacrylate with or without Ethiodized oil (Lipidol) in patients with hydrosalpinx prior to IVF
Detailed Description
hysteroscopic injection of iso-amyl- 2-cyanoacrylate with or without Ethiodized oil (Lipidol) in patients with hydrosalpinx requiring IVF. after one months and two months of the primary injection hyst...
Eligibility Criteria
Inclusion
- • Infertile women due to tubal factor with hydrosalpinx (unilateral or bilateral) prepared for IVF
Exclusion
- • Any patient with acute pelvic inflammatory disease, endometritis, lower genital tract infection.
- The presence of intrauterine synechiae that might hinder the proper hysteroscopic examination and tubal cannulation diagnosed by diagnostic hysteroscopy.
- The presence of uterine anomalies that might hinder the proper hysteroscopic examination and tubal cannulation diagnosed by diagnostic hysteroscopy.
- Undiagnosed genital bleeding.
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 10 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06130072
Start Date
November 10 2023
End Date
March 10 2024
Last Update
November 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.